Notice2026-00329

Center for Scientific Review; Notice of Closed Meetings

Primary source

Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.

Published
January 12, 2026

Issuing agencies

Health and Human Services DepartmentNational Institutes of Health

Full Text

<html>
<head>
<title>Federal Register, Volume 91 Issue 7 (Monday, January 12, 2026)</title>
</head>
<body><pre>
[Federal Register Volume 91, Number 7 (Monday, January 12, 2026)]
[Notices]
[Pages 1193-1194]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2026-00329]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Center for Scientific Review; Notice of Closed Meetings

    Pursuant to section 1009 of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Fellowships: Biochemistry, Chemistry & Biophysics.
    Date: February 2, 2026.
    Time: 10:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Address: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892.
    Meeting Format: Virtual Meeting.
    Contact Person: Dennis Pantazatos, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 594-2381, 
<a href="/cdn-cgi/l/email-protection#f89c9d9696918bd68899968c9982998c978bb8969190d69f978e"><span class="__cf_email__" data-cfemail="bfdbdad1d1d6cc91cfded1cbdec5decbd0ccffd1d6d791d8d0c9">[email&#160;protected]</span></a>.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Fellowships: Addiction, Learning and Mental Health Training 
Grants.
    Date: February 6, 2026.
    Time: 11:00 a.m. to 12:30 p.m.
    Agenda: To review and evaluate grant applications.

[[Page 1194]]

    Address: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892.
    Meeting Format: Virtual Meeting.
    Contact Person: Brian Hoshaw, Ph.D., Acting Review Chief, 
National Eye Institute, National Institutes of Health, Division of 
Extramural Research, 6700 B Rockledge Drive, Suite 3400, Rockville, 
MD 20892, 301-402-0566, <a href="/cdn-cgi/l/email-protection#224a4d514a435540624f434b4e0c4c4b4a0c454d54"><span class="__cf_email__" data-cfemail="10787f6378716772507d71797c3e7e79783e777f66">[email&#160;protected]</span></a>.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Fellowships: Neurodegenerative Disorders, Neuroplasticity and 
Cognitive Dysfunction.
    Date: February 10-11, 2026.
    Time: 9:30 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Address: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892.
    Meeting Format: Virtual Meeting.
    Contact Person: Suzan Nadi, Ph.D., Scientific Review Officer, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Drive, Room 5217B, MSC 7846, Bethesda, MD 20892, (301) 
435-1259, <a href="/cdn-cgi/l/email-protection#f59b94919c86b5968687db9b9c9ddb929a83"><span class="__cf_email__" data-cfemail="fe909f9a978dbe9d8d8cd0909796d0999188">[email&#160;protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program Nos. 93.306, 
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893, 
National Institutes of Health, HHS)

    Dated: January 8, 2026.
Rosalind M. Niamke,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2026-00329 Filed 1-9-26; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
Indexed from Federal Register on January 12, 2026.

This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.